The latest insights from experts at Niederer Kraft Frey.
The moving boundaries of arbitrability in the Life Sciences sector: is there any room for ADR in produ...
Performance meets payoff: Crafting win-win earnout agreements
Online influencers, digital media, and pharmaceutical advertisement
Distribution Agreements: A Cross-Perspective Between Commercial Strategy and Litigation
Haftung 4.0 – Medizinprodukte zwischen Innovation, Regulierung und Risiko
Marktbeherrschung – Relative Marktmacht (Dominance – Relative Market Power)
Switzerland Moves to Regulate Space Operations — A New Legal Orbit for the Swiss Space Industry
New limits for use of supervisory information in criminal proceedings
Amendment to the Swiss Telecommunications Surveillance Laws Application Scope: Opening of Public Consu...
The EU AI Act Enters into Force: Implications for Swiss Companies
Competition Commission (COMCO) rules for the first time in a case on relative market power – COMCO d...
Financial Market Infrastructure Act: Implications for listed Companies, their Managers, and Investors
Mitwirkungspflichten im FINMA-Enforcementverfahren und Verwertbarkeit in Strafverfahren
War on Drugs mit Instrumenten der Terrorismusbekämpfung: Was bedeutet das für die Compliance?
FINMA-Auskünfte ohne nemo-tenetur-Hinweis sind strafrechtlich nicht verwendbar (Bundesgerichtsurteil ...
Kritik aus Strassburgund Luxemburg
Entwicklungen im Zivilprozessrecht (1/2) | Le point sur la procédure civile (1/2)
Retrozessionen: Neuster Stand der Rechtsprechung und Einordnung
